系统性硬化症肠道微生物组-代谢组失调的多组学研究
该研究对15例系统性硬化症(SSc)患者和33例健康对照的粪便进行鸟枪法宏基因组测序,并对14例SSc患者和30例对照的血浆进行非靶向代谢组学分析,发现SSc中11种微生物物种和266种MS2鉴定的代谢物显著改变,微生物-代谢物关联分析揭示168个显著关联,提示肠道微生物组-代谢组界面紊乱参与SSc发病。
要点
- SSc患者肠道中Escherichia coli、Lactobacillus mucosae和Parabacteroides distasonis升高,而Phocaeicola plebeius、Blautia hansenii和Agathobaculum butyriciproducens在对照组富集。
- SSc患者血浆中脂类分子和氨基酸水平显著降低,氨基酸生物合成通路(包括L-异亮氨酸和L-甲硫氨酸)耗竭。
- 微生物与代谢物之间存在168个显著关联,疾病富集物种显示特定代谢联系。
核心结论
- SSc患者存在肠道微生物组与血浆代谢组的界面失调,为SSc发病机制提供了新视角和潜在治疗靶点。
研究设计与样本
- 对15例SSc患者和33例健康对照的粪便样本进行深度鸟枪法宏基因组测序。
- 对14例SSc患者和30例对照的血浆样本进行非靶向液相色谱-串联质谱代谢组学分析。
主要发现
- SSc患者与对照相比有11种微生物物种和266种MS2鉴定的代谢物显著改变。
- SSc患者中Escherichia coli、Lactobacillus mucosae和Parabacteroides distasonis水平升高。
- 对照组中Phocaeicola plebeius、Blautia hansenii和Agathobaculum butyriciproducens富集。
- 功能预测提示SSc患者氨基酸生物合成通路耗竭,包括L-异亮氨酸和L-甲硫氨酸。
- 代谢组学分析显示SSc患者脂类分子和氨基酸水平显著降低,丙氨酸、天冬氨酸和谷氨酸代谢等通路失调与SSc发展相关。
关键数值与推荐
- 鉴定出168个显著的微生物-代谢物关联,疾病富集物种显示特定代谢联系。
临床怎么用
- 提示调节肠道微生物组-代谢组界面可能成为SSc的潜在治疗策略,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The interplay between the gut microbiome (GM), plasma metabolites and systemic sclerosis (SSc) has not been systematically studied. We hypothesized that disruption at the GM-metabolome interface contributes to the pathogenesis of SSc. This study aims to investigate the faecal microbiome composition and plasma metabolite profiles in SSc patients. METHODS: To evaluate the interactions, deep shotgun metagenomic sequencing was conducted on faecal samples from 15 SSc patients and 33 healthy controls. Simultaneously, untargeted liquid chromatography-tandem mass spectrometry metabolomic profiling was performed on plasma samples from 14 SSc patients and 30 controls. RESULTS: The analysis revealed significant alterations in 11 microbial species and 266 MS2-identified metabolites in SSc patients vs controls. In SSc, elevated levels of Escherichia coli, Lactobacillus mucosae and Parabacteroides distasonis were noticed. Conversely, Phocaeicola plebeius, Blautia hansenii and Agathobaculum butyriciproducens were enriched in the control group. Functional predictions indicated a depletion of amino acid biosynthesis pathways, including L-isoleucine and L-methionine, in SSc patients. The metabolomic analysis demonstrated a significant reduction in lipid-like molecules and amino acid levels in SSc patients. Dysregulated pathways, such as alanine, aspartate and glutamate metabolism, arginine and proline metabolism, and glycine, serine and threonine metabolism, were associated with the development of SSc. Striking microbiota-metabolite correlations (168 significant associations) were identified, with disease-enriched species showing specific metabolic linkages. CONCLUSIONS: This study offers a comprehensive characterization of the disrupted GM-metabolite interface in SSc patients, providing new perspectives on SSc pathogenesis and potential therapeutic targets.
引用
- Yao QC, Zhang DY, Du YP, et al. Gut microbiome-metabolome dysregulation in systemic sclerosis: a multi-omics study. Rheumatology (Oxford). 2026. PMID: 41408356. doi:10.1093/rheumatology/keaf668
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。